Piramal Pharma Moat Analysis: Score & Risks
Piramal Pharma Ltd.
A first-pass moat teardown of Piramal Pharma Ltd., built from single-pass filing evidence. Free note — provisional, and the full two-pass deep dive may revise it.
First-pass narrow read — primary edge in Intangible Assets. Provisional, single-pass evidence.
Piramal Pharma Ltd. scores 5.28 on MoatSCORE 6.0 — a narrow moat in Pharma. This is a first-pass note: the dimensional read and the filing receipts below come from a single GFIP evidence pass, not the full two-pass deep corpus behind our flagship deep dives. Provisional — published free while the deep version is queued.
Seven dimensions of moat
Ordered by contribution. Each dimension carries a verified filing quote, graded [M] mechanism or [O] outcome.
“our brand Gablofen ranks as the number one brand in the US market in the Baclofen pre-filled syringe and vial category.”
“The Company has 100% tech-enabled sales coverage and leverages analytics to enhance the productivity of its field force.”
“Solvent recovery improvement to generate savings of H 5.65 Crores by utility upgradation and Loss reduction.”
“These are all facilities that are generally capacity constrained, and these are all facilities that generally serve on-patented client work.”
“Partner with customers as 35+ Phase III projects transition development to registration to commercial”
“undertaking judicious price increases where there is high price elasticity”
D8 rating: ADEQUATE. Not part of the moat score — it governs the cost of equity and the fade window. First-pass; not yet deep-reviewed.
The barrier gate — first-pass
Effective barrier 5 — below 6, so the band is capped narrow. First-pass estimate.
Deep two-pass review. This draft rests on a single GFIP evidence pass; the full 10-year AR + concall corpus may move the read.
The barrier gate. A firmer replication or bypass estimate is the most likely thing to shift the band.
Adverse events. Any governance, regulatory or funding shock captured in D8 could re-rate the fade window.
Where this note fits. This company is one of 509 Indian companies we have scored for moat durability — 370 narrow, 126 narrow-trending-wide, none wide. Every score, dimension by dimension, is free in the Moat Screener.
Member discussion